IMMUNOMEDICS INC - NOTE 4.750% 2/1

CUSIP: 452907AK4

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Debt / NOTE 4.750% 2/1
Market price (% of par)
381.05%
Total 13F principal
$7,114,000
Principal change
+$9,000
Total reported market value
$27,105,000
Number of holders
2
Value change
+$34,282
Number of buys
1

Quarterly Holders Quick Answers

What is CUSIP 452907AK4?
CUSIP 452907AK4 identifies 452907AK4 - IMMUNOMEDICS INC - NOTE 4.750% 2/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IMMUNOMEDICS INC - NOTE 4.750% 2/1 as of Q1 2019

As of 31 Mar 2019, IMMUNOMEDICS INC - NOTE 4.750% 2/1 was held by 2 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $7,114,000 in principal (par value) of the bond. The largest 2 bondholders included WOLVERINE ASSET MANAGEMENT LLC and CALAMOS ADVISORS LLC. This page lists 2 institutional bondholders reporting positions for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.